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Tuesday, March 3, 2009 445ametals to an LNR via isothermal titration calorimetry (ITC). In this work, we
used a combination of computer modeling and experimental approaches to
characterize and compare the Ca2þ binding affinities and coordination geome-
tries of various LNR sequences from different proteins. We expect this work to
elucidate the basis for Ca2þ ion selectivity by the LNRs that is integral for their
structural integrity and is required for the proper regulation of the Notch signal-
ing pathway.
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Previous research has led to the discovery that the plasma membrane signaling
protein PLCb1 is sometimes present in the nucleus. Little is known how PLCb1
is regulated in the nucleus on the plasma membrane. PLCb1 activity is regu-
lated by G proteins but these have not been found in the nucleus. The focus
of this study is to find binding partners for nuclear PLCb1 and investigate their
role in the regulation of its activity in the nucleus. A protein called translin-as-
sociated factor-X, TRAX, has been identified as a potential binding partner for
nuclear PLCb1. The work done in this report shows that the two proteins bind
in vitro and in living cells. Using a combination of biophysical and biochemical
methods, we find the two proteins interact and that TRAXmay regulate nuclear
PLCb1 activity.
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The human pregnane X receptor (PXR) is a transcriptional regulator of many
genes involved in xenobiotic metabolism and excretion. Human PXR activators
include an extensive range of structurally diverse endogenous molecules, drugs
which potentially result in potential drug-drug interactions. Reliable prediction
ofmolecules interactingwith this receptor would be valuable for pharmaceutical
drug discovery and environmental applications. In the current study, computa-
tionalmodels for humanPXRactivators andPXRnon-activatorswere developed
using support vector machine (SVM) algorithms using Shape Signatures and
MOEdescriptors. Themodelswere validated using separate test sets. The overall
test set prediction accuracy for PXR activators with SVMwas 72 to 81 % in line
with a previous study usingVolSurf descriptors and SVM.We have also used the
rigorous docking program GOLD and coupled the GoldScore with other scoring
functions in an attempt to improve docking results from those previously at-
tained. In this study, the best docking prediction accuracy (61 %) was obtained
using 1D Shape Signature descriptors as a weighting factor to the GoldScore.
We have also combined the available human PXR data sets into a single larger
model (~300 molecules) and described the specific molecular descriptors that
we demonstrate can help predict whether a molecule activates PXR. These com-
bined computational approaches could enable us to more confidently identify
PXR activators and to further avoid them in various applications.
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Upon substrate binding the isolated plasma membrane H(þ)-ATPase (Pma1)
from Kluyveromyces lactis displays large changes in fluorescence intensity
(Sampedro et al, 2007 Biochemistry 46:5616-5622). The nucleotide binding
domain (N-domain) contains one Trp505 residue, that seems to be responsible
for the variations in intrinsic fluorescence. The N-domain was cloned and the
protein expressed in E. coli. The purified N-domain displayed nucleotide-de-
pendent (ATP and ADP) quenching of fluorescence similar to that observed
in the whole Pma1. The dissociation constants (Kd) for ATP and ADP were
100 and 110 uM respectively. Fluorescence resonance energy transfer
(FRET) studies were also performed by using mantATP; a fluorescent ATP an-
alog (Ex. 337 nm, Em. 423nm). The absorbance spectra of mantATP overlaps
the fluorescence spectra of the N-domain, and thus FRET was observed by
exciting at 280 nm. FRET efficiency was 100% indicating a close proximity
between Trp505 and the nucleotide. Therefore, in this domain there is a Trpresidue located near the substrate binding site which is of high value to deter-
mine Kds and molecular distances using fluorescence.
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Long QT syndrome (LQTS) is a cardiac muscle abnormality caused either by
congenital or drug-induced malfunctioning of potassium channels localized in
the myocardium cell membranes. LQTS can lead to ventricular arrhythmia and
sudden cardiac death. A number of prescription medications inducing long QT
have been withdrawn from the market over the past decades, and virtually all
cases of drug-induced LQTS are due to the blockade of the heart human
ether-a-go-go-related-gene (hERG) potassium channel. Evidences show that
most of the hERG-channel blockers would exert their activity by binding one
or several sites located in the pore region composed of the last two TM helices
(S5 and S6) or on the extracellular region connecting S5 and S6 together. In this
work, we studied the binding of 4 cardiotoxic drugs (bepridil, cetirizine, di-
phenhydramine, pentamidine) with a portion of the extracellular segment
(Ile583 - Tyr597) of the hERG channel and a model membrane. Drug-peptide in-
teractions were studied using 1H liquid-state NMR with pulsed field gradient
self-diffusion measurements. According to our CD and 1H NMR results, the
peptide appears to be unstructured both in water and membrane mimetic isotro-
pic bicelles. Diffusion measurements suggest that there is no or only weak drug
binding to the peptide. However, a strong interaction with the model membrane
was evidenced for the bepridil molecule, thus suggesting a potential role of the
membrane in the cardiotoxicity of LQTS-active drugs. Our current work, which
focuses on drug-membrane interactions and hERG peptide-membrane interac-
tions by 31P and 2H solid-state NMR will also be presented.
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Toxic metals are known to displace physiologically-relevant metal ions in pro-
teins, and may activate or deactivate protein function in response to changes in
the free metal concentration. To investigate potential relationships between
metal/protein complexes and toxicity, an analysis of proteins structural and
sequential data was used to establish statistical bases for identifying key selec-
tivity factors associated with Pb2þ-protein binding. These data led us to hypoth-
esize that Pb2þ, and potentially other toxic metals, may induce opportunistic
binding in regions of negative electrostatic potential, thus altering the proteins
conformation.
To compare structural/conformational changes, investigate selectivity and
affinity, and probe the mechanism of toxic metal-protein interactions, several
natural and engineered Ca2þ-binding proteins (CaBPs) were analyzed using
Fluorescence, CD and 1D and 2D NMR spectroscopy. Engineered proteins
were developed based on grafting methods that involved insertion of metal-
binding motifs in flexible regions of protein scaffolds to investigate biophysical
properties associated with binding reactions in isolated sites. Additionally, the
ubiquitous signaling protein calmodulin (CaM) was evaluated extensively to
determine changes associated with competitive binding between Ca2þ and
anthropogenically available toxicants such as Pb2þ, Gd3þ, La3þ, Tb3þ and
In3þ. Results suggest that certain toxic metals may not only displace the biolog-
ically-relevant metals in metalloproteins, but support our hypothesis that op-
portunistic binding occurs in non-sites. This has important implications for
the potential binding of toxic metals by non-metalloproteins, as well as provid-
ing a basis for understanding the impact of toxicity related to downstream
protein-protein interactions.
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The chloride/proton transporter ClC-5 mediates the re-absorption of filtered
proteins in the kidney by promoting the formation of the macromolecular en-
docytic complex and by aiding in endosomal acidification upon complex
internalization in proximal tubule cells. Mutations disrupting ClC-5 lead to
proteinuria reflecting a severe impairment of renal receptor endocytosis and
